Mendus AB, a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, entered into a manufacturing alliance with NorthX Biologics AB. NorthX is a contract development and manufacturing organization (CDMO) and serves as the National Swedish Innovation Hub for the GMP manufacture of biologics used in vaccines, gene therapy and other advanced therapy medicinal products (ATMPs). Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which w...